Despite the widespread availability of effective prophylactic vaccines to prevent human
papillomavirus (HPV) infection, HPV remains a major health burden. For health care …

For decades, research on the pathogenesis of papillomavirus-induced lesions, particularly
of human papillomavirus (HPV) has relied on the use of animal models. Among these, HPV …

Recurrent respiratory papillomatosis (RRP) is currently treated with repeat surgical resection
of papillomatous disease that does not address the fundamental underlying issue of chronic …

Background Recurrent respiratory papillomatosis (RRP) is a currently incurable benign
neoplasm caused by human papilloma virus (HPV) infection. It usually reduces voice …

Currently available vaccines prevent HPV infection and development of HPV-associated
malignancies, but do not cure existing HPV infections and dysplastic lesions. Persistence of …

Most of the knowledge about human skin homeostasis, development, wound healing, and
diseases has been accumulated from human skin biopsy analysis by transferring from …

Juvenile-onset recurrent respiratory papillomatosis (JoRRP) is driven by human
papillomavirus (HPV) low-risk strains and is associated with significant morbidity. While …

Objective Laryngeal human papillomavirus (HPV) infection causes recurrent respiratory
papillomatosis (RRP) and accounts for up to 25% of laryngeal cancers. Lack of satisfactory …

Simple Summary Although it is known that low-risk HPV causes juvenile-onset recurrent
respiratory papillomatosis (JoRRP), viral factors such as HPV strain are not routinely …

Recurrent respiratory papillomatosis (RRP) is a neoplastic disorder that manifests as
papillomatous growths in the upper aerodigestive tract. The symptom profile, socioeconomic …